OMNIX MEDICAL: UN PAPILLON CONTRE ACINETOBACTER BAUMANNII

Une nouvelle technologie inspirée par la nature pour éradiquer de dangereuses bactéries multirésistantes. (A new technology inspired by nature to eradicate dangerous multiresistant bacteria.)

BIOTECHFINANCES, Lundi 15 février 2021

More To Explore

OMNIX MEDICAL ANNOUNCES SUCCESSFUL $8.5 MILLION FUNDING ROUND

Omnix Medical, a Jerusalem-based biopharmaceutical company, has completed an $8.5 million round led by Tal Capital (US) and Entrée Capital (IL) in association with UK based businessman Vincent Chenkwiz of CBG Group (UK) and joined by Xenia Ventures (IL) VLX Ventures (IL) and the Israeli Innovation Authority (IIA). Since its inception, the company has raised $10M.